DISPOSITION KINETICS OF DISOPYRAMIDE IN HUMAN HEALTHY-VOLUNTEERS DESCRIBED BY AN OPEN 3 COMPARTMENT MODEL

被引：4
作者：
BONDE, J
JENSEN, NM
PEDERSEN, LE
ANGELO, HR
RASMUSSEN, SN
TRAPJENSEN, J
KAMPMANN, JP
机构：
[1] FREDERIKSBERG HOSP,DEPT CLIN PHYSIOL,DK-2000 COPENHAGEN,DENMARK
[2] BISPEBJERG HOSP,DEPT INTERNAL MED P,DK-2400 COPENHAGEN NV,DENMARK
[3] BISPEBJERG HOSP,DEPT CLIN CHEM,DK-2400 COPENHAGEN NV,DENMARK
[4] ROYAL DANISH SCH PHARM,DEPT PHARMACOL,DK-2100 COPENHAGEN O,DENMARK
来源：
PHARMACOLOGY & TOXICOLOGY | 1989年 / 64卷 / 05期
关键词：
D O I：
10.1111/j.1600-0773.1989.tb00677.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：412 / 416
页数：5
相关论文
共 22 条
[1]   A HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF DISOPYRAMIDE, LIDOCAINE AND THEIR MONODEALKYLATED METABOLITES [J].
ANGELO, HR ;
BONDE, J ;
KAMPMANN, JP ;
KASTRUP, J .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1986, 46 (07) :623-627
[2]   THE INFLUENCE OF AGE AND SMOKING ON THE ELIMINATION OF DISOPYRAMIDE [J].
BONDE, J ;
PEDERSEN, LE ;
BODTKER, S ;
ANGELO, HR ;
SVENDSEN, TL ;
KAMPMANN, JP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (05) :453-458
[3]   HEMODYNAMIC-EFFECTS AND KINETICS OF CONCOMITANT INTRAVENOUS DISOPYRAMIDE AND ATENOLOL IN PATIENTS WITH ISCHEMIC-HEART-DISEASE [J].
BONDE, J ;
PEDERSEN, LE ;
ANGELO, HR ;
TRAPJENSEN, J ;
SVENDSEN, TL ;
KAMPMANN, JP .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (02) :161-166
[4]   RELATIONSHIP BETWEEN ALPHA-1-ACID GLYCOPROTEIN AND PLASMA-BINDING OF DISOPYRAMIDE AND MONO-N-DEALKYLDISOPYRAMIDE [J].
BREDESEN, JE ;
KIERULF, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (05) :779-784
[5]   THE INFLUENCE OF PROTEIN-BINDING ON DISOPYRAMIDE CLEARANCE [J].
BRYSON, SM ;
LAWRENCE, JR ;
STEELE, WH ;
CAMPBELL, BC ;
ELLIOTT, HL ;
SUMNER, DJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 23 (05) :453-456
[6]   EFFECTS OF URINE PH AND PLASMA-PROTEIN BINDING ON RENAL CLEARANCE OF DISOPYRAMIDE [J].
CUNNINGHAM, JL ;
SHEN, DD ;
SHUDO, I ;
AZARNOFF, DL .
CLINICAL PHARMACOKINETICS, 1977, 2 (05) :373-383
[7]   EFFECT OF NONLINEAR DISPOSITION KINETICS ON SYSTEMIC AVAILABILITY OF DISOPYRAMIDE [J].
CUNNINGHAM, JL ;
SHEN, DD ;
SHUDO, I ;
AZARNOFF, DL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (04) :343-346
[8]   THE EFFECT OF SATURABLE BINDING TO PLASMA-PROTEINS ON THE PHARMACOKINETIC PROPERTIES OF DISOPYRAMIDE [J].
GIACOMINI, KM ;
SWEZEY, SE ;
TURNERTAMIYASU, K ;
BLASCHKE, TF .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (01) :1-14
[9]  
GIBALDI M, 1975, PHARMACOKINETICS, P119
[10]   PHARMACOKINETICS OF ANTIARRHYTHMIC DISOPYRAMIDE IN HEALTHY HUMANS [J].
HINDERLING, PH ;
GARRETT, ER .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (03) :199-230
123